Your cart is empty

Have an account? Log in to check out faster.

Continue shopping
HOLYPATH
Call us
+82 10 8164 1410
Email us
info@holypathglobal.com
Working Hours
Mon. - Fri. 9AM - 7PM

HA Filler With Lidocaine: Does It Reduce Pain Safely?

Kiara Reju skin booster with lidocaine product box

An HA filler with lidocaine is a hyaluronic acid gel that contains a small amount of local anesthetic, most commonly 0.3% lidocaine, so injections are more comfortable. Published reviews report significantly lower injection pain with no documented loss of efficacy or duration, although clinicians should still check each product's labeling.

Key Takeaways

  • Reviewed studies consistently report less pain during and after injection with lidocaine-containing HA fillers.
  • 0.3% is the concentration most often cited in the literature; always verify the figure on the product's instructions for use.
  • No documented compromise to efficacy or duration of action was found in the reviewed clinical literature.
  • Pre-incorporated lidocaine is generally easier to standardize than clinician-added lidocaine.
  • For buyers, confirm composition, certification and batch documentation before stocking any lidocaine-containing product.

What Does Lidocaine Do in an HA Filler?

Lidocaine is an amide-type local anesthetic that blocks nerve conduction at the injection site. When it is built into the gel, it is released into the surrounding tissue during and after placement, which reduces the pain felt by the patient.

Manufacturers add it to the finished gel; the Smith and Cockerham review lists examples of pre-incorporated products such as Restylane-L, Perlane-L and Juvederm Ultra Plus. The aim is a more tolerable treatment without a separate anesthetic step for every patient, although topical or regional anesthesia may still be chosen by the practitioner for sensitive areas.

Is an HA Filler With Lidocaine Less Painful?

Yes, according to the available evidence. Smith and Cockerham (Patient Preference and Adherence, 2011) reviewed studies comparing HA fillers with and without lidocaine and reported that all of them found significantly less pain during and after injection with lidocaine. The review cites individual trials with pain scores such as 3.6 versus 5.8 and 2.0 versus 5.3 on the scales used in those studies.

These scores come from different trials and scales and should not be pooled or treated as expected results. Pain also depends on needle or cannula choice, injection speed, site and individual sensitivity. Some of the reviewed studies also suggested less swelling, redness and bruising, but the authors note that epinephrine use may confound this.

Does Lidocaine Affect Filler Efficacy or Longevity?

The reviewed literature reports no documented compromise to efficacy or duration of action with adjunctive lidocaine. A separate 2022 preclinical study in Pharmaceutics (Brusini et al., Teoxane SA) added 0.3% w/w lidocaine or mepivacaine to two HA fillers and found no significant differences between the two anesthetics in rheology, 36-month shelf-life phase angle, or hyaluronidase degradation times.

Interpret this cautiously: the authors are employees of the manufacturer, only two products were tested, and the work was in vitro plus a small rat study. It supports the idea that the anesthetic does not obviously destabilize a well-formulated gel, but it does not replace the clinical data and instructions for use of the specific product you stock.

Pre-Incorporated vs Clinician-Added Lidocaine: What Is the Difference?

Pre-incorporated lidocaine is added by the manufacturer under controlled conditions, whereas clinician-added lidocaine is mixed at the point of care. The review describes the clinician-added technique using a two-way connector or female-to-female adaptor, first attributed to Dr. Mariano Busso, and raises concerns about product quality, sterility, volume and flow characteristics.

Factor Pre-incorporated lidocaine Clinician-added lidocaine
Who adds the anesthetic Manufacturer Practitioner at point of care
Standardization Defined concentration on the label Depends on technique and volumes mixed
Sterility control Manufacturing process Additional handling step
Labeling Within the product's instructions for use May fall outside manufacturer labeling
Concern raised in the review None specific to the concept Quality, sterility, volume, flow characteristics

Who Should Not Receive a Lidocaine-Containing Filler?

Patients with a known hypersensitivity to amide-type local anesthetics should be assessed carefully before treatment. True lidocaine allergy is described as rare, but the review advises considering it during history-taking and consent, including prior use of over-the-counter anesthetics.

Adding lidocaine did not significantly change the overall side-effect profile of HA fillers in the review. The usual filler risks, including nodules and vascular events, still apply and are not specific to lidocaine; see our guides on HA filler nodules and the prevention and management of vascular occlusion. Practitioners should follow each product's contraindications and local regulations.

What Should Clinics and Distributors Check When Sourcing?

Confirm the exact composition, the lidocaine concentration, the certification status for your market and the batch documentation before you stock the product. Pages often omit details, so request the instructions for use directly from the supplier.

  • Is lidocaine pre-incorporated, and at what stated concentration?
  • What certification or registration does the product hold in your target market?
  • Are storage and shelf-life conditions documented?
  • Can the supplier provide batch-level documents? See our checklist of documents to request from wholesale suppliers.

Examples in the HolyPath range include Restylane (Galderma) and Kiara Reju with lidocaine. For background on how fillers differ from injectable boosters, read Skin Boosters vs Dermal Fillers and our Restylane NASHA vs OBT comparison. Lidocaine content and approvals differ by product and country, so verify each one individually.

What Are Common Misconceptions About Lidocaine in Fillers?

The most common misconception is that lidocaine makes a filler last longer or look better; the reviewed literature only supports a comfort benefit with no documented loss of efficacy. A second is that lidocaine makes a filler safer. The review found no significant change in the overall side-effect profile, so vascular, infectious and nodular risks remain and must be managed by technique and preparedness.

A third is that all lidocaine fillers are interchangeable. Gel chemistry, cross-linking, particle characteristics and labeled indications differ between products, so a pain-reduction finding for one filler cannot be assumed for another. Evaluate each product on its own documentation.

How Should Practitioners Counsel Patients About Lidocaine Fillers?

Counseling should cover what lidocaine does and does not do: it improves comfort but does not guarantee a pain-free session, and it does not change the need for a qualified injector. Results and tolerability vary between patients.

A sensible consent process includes a medication and allergy history, a note of any previous reaction to dental or topical anesthetics, and a clear explanation of expected post-treatment effects such as swelling or redness. Document the product name, lot number and expiry date in the patient record, as with any injectable. Lidocaine does not replace aseptic technique, anatomical knowledge or a plan for managing complications, including ready access to hyaluronidase for HA products. For depth, spacing and needle considerations in superficial treatments, see our guide to skin booster injection technique.

Patient comfort also affects clinic operations. A more tolerable procedure can reduce the need for separate anesthetic steps in some workflows, but the choice between topical anesthesia, a pre-incorporated product or regional blocks remains a clinical decision for the treating practitioner, made in line with local regulations and the manufacturer's instructions.

Frequently Asked Questions

Does lidocaine in HA filler reduce injection pain?

Yes. A literature review by Smith and Cockerham (2011) found that every reviewed study reported significantly less pain during and after injection when lidocaine was added to HA filler. Individual pain scores and techniques vary, so lidocaine-containing fillers reduce discomfort for many patients but do not remove it entirely.

Does lidocaine change how long an HA filler lasts?

The reviewed clinical literature reported no documented compromise to efficacy or duration of action with adjunctive lidocaine. A manufacturer-sponsored 2022 preclinical study also found no significant effect on gel stability over a 36-month shelf-life study. Duration still depends on the product, site, technique and patient.

What concentration of lidocaine is typical in HA fillers?

Most studies in the Smith and Cockerham review used filler containing 0.3% lidocaine, and a 2022 Pharmaceutics paper describes 0.3% w/w as the standard concentration in HA fillers since 2005. Always confirm the exact concentration on the specific product's instructions for use, as it can differ.

Is it acceptable to mix lidocaine into filler at the clinic?

Clinician-added lidocaine has been described using a two-way connector, but the review raised concerns about product quality, sterility, volume and flow characteristics. Mixing may also fall outside the manufacturer's labeling. Many clinics prefer pre-incorporated products, and local regulations and the product's instructions for use should guide the decision.

Who should avoid lidocaine-containing fillers?

True lidocaine allergy is rare, but the review advises considering it during history-taking and consent, including prior local anesthetic reactions. Practitioners should screen for known amide anesthetic hypersensitivity and follow the product's contraindications. Patients with such a history may need a plain, non-lidocaine alternative.

Conclusion

Lidocaine-containing HA fillers are a well-studied way to improve injection comfort, with no documented loss of efficacy in the reviewed literature. For clinics and distributors, the practical task is verifying composition, concentration and documentation for each product. To discuss wholesale supply, send an inquiry to HolyPath.

References

This article is for informational purposes for licensed medical professionals and distributors. It is not medical advice. Treatments should be performed only by qualified practitioners in accordance with local regulations.